Hallucinogens alter perception, mood, and thought processes, often producing vivid visual and auditory changes, distortions in the sense of time, and shifts in how you experience your own identity. The specific effects vary widely depending on the type of hallucinogen, the dose, and the person taking it. These substances fall into distinct categories that work through different brain systems, and understanding those categories is the clearest way to make sense of their very different effects.
Three Categories, Three Types of Effects
Hallucinogens are generally grouped by how they act in the brain. Classic psychedelics like LSD, psilocybin (magic mushrooms), and DMT primarily influence serotonin signaling. They bind to specific serotonin receptors located high in the brain’s processing hierarchy, which is why they can produce such powerful changes in consciousness: vivid visions, altered sense of self, and feelings of deep connection or insight.
Dissociative drugs like ketamine and PCP work through an entirely different system. They block receptors involved in glutamate signaling, another key chemical messenger in the brain. The hallmark effect is a feeling of disconnection from your body and surroundings. Many people describe floating, watching themselves from outside, or feeling like their environment isn’t quite real.
A third group doesn’t fit neatly into either category. MDMA triggers the brain to release serotonin while also boosting dopamine and norepinephrine, which is why its effects blend perceptual changes with intense emotional warmth and heightened attention. Salvia works on the brain’s opioid system rather than serotonin or glutamate, producing brief but intensely disorienting experiences. Ibogaine affects a wide range of brain receptors simultaneously.
What Happens in Your Body
Most hallucinogens trigger a set of physical responses that overlap with a stress reaction. Your pupils dilate, your heart rate and blood pressure climb, and your body temperature rises. For classic psychedelics at typical doses, these changes are modest and not medically dangerous on their own.
Dissociatives can produce more unpredictable physical effects. PCP at low to moderate doses causes a noticeable rise in blood pressure and pulse, but at high doses this can reverse, with blood pressure, pulse, and breathing all dropping. PCP is also more likely than other hallucinogens to cause seizures and significant confusion.
LSD is considered extremely safe from a purely physiological standpoint at standard doses. An estimated 31 million Americans have used LSD at some point, with no documented deaths from the drug itself at recreational doses. The estimated lethal dose for a human would be roughly 800 to 1,600 times a typical street dose. The rare fatalities linked to LSD in case reports involved either dangerous physical restraint by police during psychological distress or substances sold as LSD that were actually something else entirely, such as synthetic compounds with severe effects on body temperature regulation.
Perceptual and Psychological Effects
The perceptual effects of hallucinogens go well beyond “seeing things that aren’t there.” Colors may intensify or shift. Geometric patterns can appear with eyes open or closed. Objects may seem to breathe, melt, or ripple. Some people experience synesthesia, where sensory channels cross: you might “see” music or “feel” colors. Moving objects can leave visual trails, and halos may appear around lights.
Time distortion is nearly universal. Minutes can feel like hours, or an entire experience that lasted several hours may feel like it passed in moments. Your sense of physical space can also shift, with objects appearing larger or smaller than they are.
One of the most distinctive psychological effects of classic psychedelics is ego dissolution, sometimes called ego death. This is a loosening or complete loss of the boundary between yourself and everything else. Your usual sense of being a separate, defined person temporarily fades. Research suggests this happens because psychedelics disrupt activity in brain networks responsible for maintaining your sense of self, particularly areas in the cingulate cortex that link self-perception with social awareness. For some people this experience is profoundly meaningful and even therapeutic. For others, it’s terrifying.
Psychedelics also appear to expand the range of mental states your brain can access. Neuroimaging research involving over 2,000 participants has shown that these drugs alter connectivity across brain networks that normally operate in more rigid patterns, particularly the network active during self-referential thinking and mind-wandering. This increased flexibility may explain why people often report gaining new perspectives on entrenched problems or emotional patterns during a psychedelic experience.
How Long the Effects Last
Duration varies enormously across substances. LSD produces effects lasting several hours, often 8 to 12. Psilocybin and mescaline also last several hours, though psilocybin tends to be somewhat shorter than LSD. Ayahuasca, a brew containing DMT along with compounds that slow its breakdown, similarly lasts for hours.
Pure DMT is the outlier. When inhaled or injected, its effects begin within seconds to minutes and are over in 10 to 30 minutes. Intramuscular administration takes slightly longer to kick in (2 to 5 minutes) and lasts up to an hour. Despite the short duration, the subjective intensity matches that of longer-acting psychedelics, compressing a full range of visions, body distortions, and mood changes into a much smaller window.
PCP and ketamine have their own timelines. Ketamine’s effects are relatively brief, while PCP is longer acting and more likely to produce prolonged confusion and delirium as it wears off.
Risks and Adverse Effects
The most common acute risk of psychedelics is psychological, not physical. A “bad trip” can involve intense anxiety, paranoia, panic, or frightening hallucinations. The experience of ego dissolution, when it feels threatening rather than liberating, can be deeply distressing. These episodes are usually time-limited and resolve as the drug wears off, but they can lead to dangerous behavior if a person is in an unsafe environment or tries to flee the experience.
A longer-term concern is hallucinogen persisting perception disorder, or HPPD. This condition involves visual disturbances that continue well after the drug has left the body: geometric patterns, flashes of color, trailing images behind moving objects, halos, and false perceptions of movement at the edges of your vision. The DSM-5 estimates that about 4.2% of hallucinogen users experience symptoms resembling HPPD at some point. Reliable prevalence data is limited, though, and the condition ranges from mildly annoying to significantly impairing daily life.
Dissociatives carry additional risks. PCP in particular can trigger severe agitation, psychosis, and unpredictable behavior at higher doses. Its effects on motor control and pain perception mean people under its influence may injure themselves without realizing it.
Therapeutic Research
Hallucinogens are being studied as potential treatments for mental health conditions that respond poorly to existing medications. The FDA has issued national priority vouchers to companies studying psilocybin for both treatment-resistant depression and major depressive disorder, a signal that the agency considers these potential treatments a public health priority.
The therapeutic interest centers on the same brain effects that make these substances powerful in the first place. By temporarily disrupting rigid patterns of self-referential thinking and increasing neural flexibility, psychedelics may allow people with depression, PTSD, or addiction to break free from entrenched thought loops. The experience of ego dissolution, in a supported therapeutic setting, appears to be one of the key predictors of lasting benefit. Early clinical results have been promising enough to push several compounds through the regulatory pipeline, though none have yet received full FDA approval for psychiatric use.